Re: Another possibility?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Another possibility?

in response to

Another possibility?

PVLee

posted on Dec 10, 2015 10:20AM

PVLee,

Welcome to the Zenith Agoracom hub. I don't know why you are having problems with the paragraph spacing. Are you on a computer or mobile device?

Your take on this new arrangment sounds reasonable, but I wasn't really clear what questions were being asked in your posts regarding IPO(s). Seems that between you and Deke there was discussion of IPO of Zenith Epigenetics Ltd and also discussion of IPO of Zenith Capital Corp. Is this correct, or am I misinterpreting the posts? To me, IPO of Zenith Epigenetics Ltd makes sense in the next 6 months. But IPO of Zenith Capital Corp doesn't make sense to me.